Literature DB >> 593430

Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

M Nielsen, C Braestrup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 593430     DOI： 10.1007/bf00505083

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  26 in total

1.  The influence of desipramine and amitriptyline on the accumulation of [3-H]noradrenaline and its two major metabolites formed from [3-H]tyrosine in the rat brain.

Authors:  M Nielsen
Journal:  J Pharm Pharmacol       Date:  1975-03       Impact factor: 3.765

2.  Estimation of noradrenaline and its major metabolites synthesized from [3H] tyrosine in the rat brain.

Authors:  M Nielsen
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

3.  Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain.

Authors:  J J Schildkraut; M Roffman; P J Orsulak; A F Schatzberg; M A Kling; T G Reigle
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1976-07

4.  Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain.

Authors:  J Schubert; H Nybäck; G Sedvall
Journal:  J Pharm Pharmacol       Date:  1970-02       Impact factor: 3.765

5.  Accumulation and disappearance of noradrenaline and its major metabolites synthesized from intraventricularly injected (3H)dopamine in the rat brain.

Authors:  C Braestrup; M Nielsen; J Scheel-Krüger
Journal:  J Neurochem       Date:  1974-09       Impact factor: 5.372

6.  Increase of noradrenaline metabolism following electrical stimulation of the Locus coeruleus in the rat.

Authors:  D S Walter; D Eccleston
Journal:  J Neurochem       Date:  1973-08       Impact factor: 5.372

7.  Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex.

Authors:  J Korf; G K Aghajanian; R H Roth
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

8.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

9.  Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex.

Authors:  R F Squires
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

10.  The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.

Authors:  C Braestrup; H Andersen; A Randrup
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432
View more
  10 in total

1.  Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

Authors:  D S Charney; A Breier; P I Jatlow; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats.

Authors:  J V Cassella; M Davis
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Studies on rat brain catecholamine synthesis and beta-adrenoceptor number following administration of electroconvulsive shock, desipramine and clenbuterol.

Authors:  V L Nimgaonkar; D J Heal; C L Davies; A R Green
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3methoxy-4-hydroxyphenylglycol.

Authors:  S W Tang; D M Helmeste; H C Stancer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

6.  Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats.

Authors:  E Przegaliński; A Kordecka-Magiera; E Mogilnicka; J Maj
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists.

Authors:  J Maj; E Mogilnicka; V Klimek
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Neonatal desipramine or zimeldine treatment causes long-lasting changes in brain monoaminergic systems and alcohol related behavior in rats.

Authors:  L A Hilakivi; D Stenberg; J D Sinclair; K Kiianmaa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities.

Authors:  T A Pugsley; W Lippmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.